Your browser doesn't support javascript.
loading
Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang, Zhibo; Yuan, Fang; Chen, Runzhe; Li, Ye; Ma, Junxun; Yan, Xiang; Wang, Lijie; Zhang, Fan; Tao, Haitao; Guo, Dong; Huang, Zhiyue; Zhang, Sujie; Li, Xiaoyan; Zhi, Xiaoyu; Ge, Xiangwei; Hu, Yi; Wang, Jinliang.
Afiliación
  • Zhang Z; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yuan F; Medical School of Chinese PLA, Beijing, China.
  • Chen R; The 78th Group Army Hospital of Chinese PLA, Mudanjiang, China.
  • Li Y; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Ma J; Departments of Thoracic/Head and Neck Medical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Yan X; Department of Radiotherapy, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Wang L; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhang F; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Tao H; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Guo D; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Huang Z; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhang S; BeiGene (Shanghai) Co., Ltd., Shanghai, China.
  • Li X; BeiGene (Shanghai) Co., Ltd., Shanghai, China.
  • Zhi X; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Ge X; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Hu Y; Department of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Wang J; Medical School of Chinese PLA, Beijing, China.
Front Immunol ; 11: 1173, 2020.
Article en En | MEDLINE | ID: mdl-32587591
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Resultado del Tratamiento / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Resultado del Tratamiento / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article